Refractory Chronic Cluster Headache: Exploring the Potential of Repetitive Transcranial Magnetic Stimulation
NCT06917144 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2025-04-08
Summary
The goal of this clinical trial is to learn if drug ABC works to treat severe asthma in adults. It will also learn about the safety of drug ABC. The main questions it aims to answer are:
Does Transcranial Magnetic Stimulation lower the number of attacks per week in patients with refractory cluster headache ?
Researchers will compare transcranial magnetic stimlation to a sham stimulation (a look-alike stimulation) to see if it works to prevent attacks of cluster headache.
Participants will:
Recieve stimulation for 10 minutes for 10 consecutive working days in 2 periods of time, separated by a 1 month washout period.
Visit the clinic for each treatment day. Keep a diary of their symptoms and the number of times they use a rescue medication
Conditions
- Refractory Chronic Cluster Headache
Interventions
- DEVICE
-
Repetitive Transcranial Magnetic Stimulation
Stimulation sessions were performed using a YINGCHI M-100 Ultimate device with liquid-cooled figure-8 coils. Patients attended 10-minute sessions daily for 10 consecutive working days. For rTMS, stimulation was delivered at an excitatory frequency of 10 Hz, targeting the M1, contralateral to the side of pain in the facial region. Each session consisted of the following steps. * 10 series: 60 pulses per series (600 pulses in total). * Rest intervals: 60 seconds between series. * Intensity: 70% of the resting motor threshold (RMT). RMT was determined using single-pulse stimulation over the M1 region controlling the abductor pollicis brevis muscle, localized via neuronavigation. The threshold was de-fined as the lowest stimulator intensity producing a motor-evoked potential amplitude \>50 µV in at least 5 of 10 trials.
- DEVICE
-
Sham Stimulation
Sham Stimulation: The same device and protocol used for intervention protocol with Repetitive Transcranial Magnetic Stimulation were used for sham stimulation, but no active stimulation was delivered. The equipment produced identical sounds and appearances, thereby ensuring blinding.
Sponsors & Collaborators
-
Hospital Universitario La Paz
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-21
- Primary Completion
- 2024-05-31
- Completion
- 2024-05-31
Countries
- Spain
Study Locations
More Related Trials
-
Circadian Changes of the Hypothalamic Activity in Patients Suffering From Cluster Headache
NCT04409977 ·Status: UNKNOWN
-
Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve Stimulation
NCT02081482 ·Status: UNKNOWN ·Phase: NA
-
Bilateral Occipital Nerve Field Stimulation for the Treatment of dtCCH
NCT06124534 ·Status: SUSPENDED ·Phase: NA
-
A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache
NCT03107052 ·Status: TERMINATED ·Phase: PHASE3
-
Eptinezumab in Participants With Episodic Cluster Headache
NCT04688775 ·Status: COMPLETED ·Phase: PHASE3
-
Pathway CH-1 Long-Term Follow-Up
NCT01616511 ·Status: COMPLETED
-
Safety and Efficacy Study of SOM230 s.c. in Cluster Headache
NCT02619617 ·Status: TERMINATED ·Phase: PHASE2
-
Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety Issues
NCT03066635 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)
NCT04814381 ·Status: COMPLETED ·Phase: PHASE4
-
Circadian Rhythm and Attack-timing in Episodic Cluster Headache Patients in- and Outside of Bout: an Actigraphic Study
NCT02853487 ·Status: COMPLETED
-
Treatment of Chronic Post-Traumatic Headache With OnabotulinumtoxinA
NCT02160535 ·Status: TERMINATED ·Phase: PHASE3
-
Occipital Transcutaneous Stimulation in Chronic Migraine
NCT02307071 ·Status: UNKNOWN ·Phase: PHASE4
-
Prevention and Acute Treatment of Chronic Cluster Headache Compared to Standard of Care
NCT01701245 ·Status: COMPLETED ·Phase: PHASE2
-
Repetitive Transcranial Magnetic Stimulation in Treatment and Prophylaxis of Chronic Migraine in Patients With no Prophylactic Treatment for the Last 3 Months
NCT06461767 ·Status: RECRUITING ·Phase: NA
-
Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption
NCT05232942 ·Status: RECRUITING
-
Sleep, Circadian Rhythms and Cluster Headache
NCT01447641 ·Status: COMPLETED
-
A Close Examination of Patient Experiences in Cluster Headache Clinical Research
NCT05978258 ·Status: NOT_YET_RECRUITING
-
The Presence and Role of Zygomatic-temporal Neuroma Triggering Cluster Headache
NCT04845451 ·Status: COMPLETED
-
Pulsed Radiofrequency Combined With Platelet-Rich Plasma Applied to the Sphenopalatine Ganglion in Treating Episodic Cluster Headache
NCT06882278 ·Status: NOT_YET_RECRUITING
-
Hypersensitivity to Opening of BKCa Channels in Post-Traumatic Headache
NCT05378074 ·Status: UNKNOWN ·Phase: NA
-
A Study of Galcanezumab in Participants With Chronic Cluster Headache
NCT02438826 ·Status: COMPLETED ·Phase: PHASE3
-
Bilateral DLPC tDCS in Drug-resistant Migraine
NCT06079801 ·Status: COMPLETED ·Phase: NA
-
Response to Combined Trigeminal and Occipital Nerve Stimulation for the Preventive Treatment in Chronic Cluster Headache
NCT07113470 ·Status: RECRUITING ·Phase: NA
-
Study of Hypothalamic Metabolism in Spontaneous Cluster Headache Attacks
NCT00458770 ·Status: TERMINATED ·Phase: NA
-
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
NCT02797951 ·Status: COMPLETED ·Phase: PHASE3